Colgate-Palmolive (NYSE:CL) Shares Bought by Mackenzie Financial Corp

Mackenzie Financial Corp boosted its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,887,963 shares of the company's stock after buying an additional 50,771 shares during the quarter. Mackenzie Financial Corp owned 0.47% of Colgate-Palmolive worth $309,910,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Vest Financial LLC raised its position in Colgate-Palmolive by 25.1% in the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company's stock valued at $29,498,000 after purchasing an additional 74,337 shares during the period. Central Bank & Trust Co. lifted its stake in Colgate-Palmolive by 22.1% during the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company's stock worth $110,000 after acquiring an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC boosted its holdings in Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company's stock valued at $864,000 after acquiring an additional 910 shares during the period. Sarasin & Partners LLP grew its position in Colgate-Palmolive by 1.2% in the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company's stock valued at $323,115,000 after acquiring an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC increased its stake in Colgate-Palmolive by 2.5% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company's stock worth $571,000 after purchasing an additional 172 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on CL. Morgan Stanley raised their price objective on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an "overweight" rating in a research note on Monday, January 29th. Stifel Nicolaus upped their price objective on Colgate-Palmolive from $89.00 to $94.00 and gave the stock a "buy" rating in a research report on Wednesday, April 10th. StockNews.com lowered Colgate-Palmolive from a "strong-buy" rating to a "buy" rating in a report on Tuesday, February 20th. UBS Group upped their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the stock a "buy" rating in a report on Monday, January 29th. Finally, Evercore ISI lifted their price objective on Colgate-Palmolive from $90.00 to $96.00 and gave the company an "outperform" rating in a research note on Monday, April 8th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of "Moderate Buy" and an average target price of $88.56.

Insider Activity

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 29,772 shares of the business's stock in a transaction on Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the transaction, the chief executive officer now directly owns 301,343 shares of the company's stock, valued at approximately $25,330,892.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Noel R. Wallace sold 50,000 shares of the company's stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares of the company's stock, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock valued at $19,505,099 in the last ninety days. 0.37% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Up 0.4 %

NYSE:CL traded up $0.32 during midday trading on Monday, hitting $86.17. 4,265,041 shares of the company were exchanged, compared to its average volume of 4,570,119. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $90.37. The company has a market capitalization of $70.83 billion, a PE ratio of 31.00, a price-to-earnings-growth ratio of 3.26 and a beta of 0.42. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. The company has a fifty day simple moving average of $86.87 and a 200 day simple moving average of $80.48.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts' consensus estimates of $0.85 by $0.02. The business had revenue of $4.95 billion for the quarter, compared to analysts' expectations of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business's revenue was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.77 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be given a dividend of $0.50 per share. The ex-dividend date is Friday, April 19th. This is a positive change from Colgate-Palmolive's previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. Colgate-Palmolive's dividend payout ratio (DPR) is 69.06%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.